https://www.biotechreality.com/2026/09/merck-spr2015-kras-g12d-inhibitor-deal.html 2026-09-28T18:18:55Z BiotechReality - Information Intelligence System for Biopharma en Merck SPR2015 KRAS G12D Inhibitor Deal Strengthens Oncology Pipeline Through $2.13 Billion Agreement 2026-09-28T18:18:50Z Blog https://www.biotechreality.com/2026/09/abbvie-juvmo-tavapadon-fda-approval-parkinsons-disease.html 2026-09-28T17:53:57Z BiotechReality - Information Intelligence System for Biopharma en AbbVie JUVMO (Tavapadon) Wins FDA Approval as First Selective D1/D5 Receptor Agonist for Parkinson's Disease 2026-09-28T17:53:52Z Blog https://www.biotechreality.com/2026/09/ifinatamab-deruxtecan-bla-withdrawn.html 2026-09-27T18:02:58Z BiotechReality - Information Intelligence System for Biopharma en Merck Ifinatamab Deruxtecan BLA Withdrawn in Previously Treated ES-SCLC 2026-09-27T18:02:53Z Blog https://www.biotechreality.com/2026/09/eli-lilly-olumiant-alopecia-areata-fda-pediatric-approval.html 2026-09-26T08:06:01Z BiotechReality - Information Intelligence System for Biopharma en Eli Lilly Olumiant Alopecia Areata Treatment Approved by FDA for Pediatric Patients 12 and Older 2026-09-26T08:05:57Z Blog